Aging
Navigate
Submit an Article
Research Paper|Volume 15, Issue 21|pp. 12369–12387
CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers
Back to articleFigure 3(3 of 7)
100%
Figure 3
Figure 3.Validation of prognostic implications of CCL19 expression for PFS in BRCA patients across independent cohorts. With 4929 BRCA samples in total, PFS analysis of independent cohorts was performed.